Over-the-counter, behind-the-counter, or by prescription only? Good question. And, it’s the question currently being debated at the Food and Drug Administration.

The issue involves whether convinced medications, currently available only by prescription, should become available after consultation with a pharmacist. This method, known as behind-the-counter, is a class in within the current division of freely available over-the-counter medications and those available only by prescription. As always, when it comes to health care, a big argument about the proposal is underway.

Proponents say the action would help many, particularly those without health insurance, obtain needed medications without first having to see a physician. The view of involving the pharmacist is to ensure proper selection and safety, and to supply adequate patient education. Certainly seems fair, and similar

systems are currently being utilized in Britain, Canada, Australia, and several European nations.

Opponents, particularly those companies manufacturing and marketing over-the-counter medications, say the current system works great and best serves the needs of the consumer. Not a surprising statement but, certainly, one to be viewed with at least a modicum of skepticism.

The FDA will hold a public meeting on November 14th to gather comments from the public.

Is the behind-the-counter model the best way to go? Well, on the surface, it certainly seems to hold the potential to increase access and reduce costs. Those are good things, right?

To read more about the proposal, see that from Reuters. To read more about the public meeting, see that (PDF) from the FDA.